Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
for Cutaneous Squamous Cell Carcinoma (CSCC)
44 locations incl. Phoenix
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06585410·Phase 3·Recruiting·Listed Sep 2024